Nigeria Launches 6-Month HIV Prevention Shot for 52,000

Nigeria is making history in the fight against HIV with a game-changing prevention tool that requires just two shots per year instead of daily pills.

The Nigerian government has begun distributing lenacapavir, a long-acting injectable drug that prevents HIV infection for six months at a time. Health Minister Dr. Iziaq Salako announced the rollout on Monday, calling it a major milestone in Nigeria's goal to end AIDS as a public health threat by 2030.

The country has secured 52,000 doses for its first phase, targeting eight states plus the capital city of Abuja. Anambra, Ebonyi, Gombe, Kwara, Akwa Ibom, Cross River, and Benue will receive the drug alongside the Federal Capital Territory.

The twice-yearly injection solves a critical problem: daily pills are hard to stick with, especially for vulnerable populations who may face stigma or lack privacy. Lenacapavir offers discreet protection without the burden of remembering medication every single day.

Health workers have already completed training, and facilities have been assessed to ensure they're ready to store and administer the drug safely. The government strengthened supply chains and monitoring systems specifically for this launch.

Dr. Temitope Ilori from the National Agency for the Control of AIDS emphasized that while global data shows the drug is highly safe, it's not yet recommended for pregnant women due to insufficient evidence. She also noted that lenacapavir only prevents HIV and doesn't protect against other sexually transmitted infections like hepatitis.

The Ripple Effect

This rollout puts Nigeria at the forefront of HIV prevention innovation in Africa. By offering multiple prevention options, from daily oral pills to long-acting injections, the country is meeting people where they are with solutions that fit their lives.

The government isn't stopping at nine regions. Dr. Adebobola Bashorun, National Coordinator of the HIV control program, confirmed they're already working to expand access and secure more doses to reach additional states and populations most at risk.

President Bola Ahmed Tinubu's administration has committed to a comprehensive approach that expands prevention, treatment, and care services across the board. This injectable drug complements existing methods rather than replacing them, giving individuals real choice in how they protect themselves.

Nigeria's bold move could inspire other African nations to adopt similar strategies, potentially saving countless lives across the continent.